-
Ʊ Releases Corporate Film “1 Percent, 1 Mission. Change the World.”
-
Human Capital Report 2024
-
Value Creation Report 2024
-
May 21, 2025
Ʊ Demonstrates Commitment to Oncology Innovation at ASCO 2025
-
May 16, 2025
Ʊ Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro®
-
May 15, 2025
Notification Regarding Partial Amendment to the Articles of Incorporation
-
May 8, 2025
-
May 1, 2025
-
May 21, 2025
-
May 16, 2025
IR “Notice of Convocation of the 113th Ordinary General Meeting of Shareholders”
-
May 15, 2025
IR “Annual Financial Results Briefing for the Fiscal Year Ended March 31, 2025 (Material)”
-
May 15, 2025
IR “Annual Financial Report for the Fiscal Year Ended March 31, 2025”
-
April 24, 2025
-
February 19, 2025
Ʊ’s Corporate Pension Fund Announces Adoption of “Asset Owner Principles”
-
October 3, 2024
EISAI NAMED AS ONE OF NEWSWEEK’S WORLD’S MOST TRUSTWORTHY COMPANIES 2024
-
June 21, 2024
Notification Regarding Revision of “Ʊ Global Code of Conduct for Business Partners”
-
June 3, 2024
The Naito Museum of Pharmaceutical Science and Industry Listed as “Registered Museum”
-
April 8, 2024
Sustainability
32 countries 2.52billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of March 2025)
Ʊ is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries